Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Merck
Express Scripts
Harvard Business School

Last Updated: August 19, 2022

Investigational Drug Information for Ubiquinol


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Ubiquinol?

Ubiquinol is an investigational drug.

There have been 13 clinical trials for Ubiquinol. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2017.

The most common disease conditions in clinical trials are Syndrome, Toxemia, and Sepsis. The leading clinical trial sponsors are Beth Israel Deaconess Medical Center, Kaneka Medical America LLC, and Kaneka Pharma America LLC.

There are nine hundred and six US patents protecting this investigational drug and eight international patents.

Recent Clinical Trials for Ubiquinol
TitleSponsorPhase
Effect of Montelukast Versus Co Enzyme in SepsisAin Shams UniversityPhase 2/Phase 3
Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical TrialCairo UniversityPhase 1
Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate ResistanceSaudi German Hospital - MadinahPhase 2/Phase 3

See all Ubiquinol clinical trials

Clinical Trial Summary for Ubiquinol

Top disease conditions for Ubiquinol
Top clinical trial sponsors for Ubiquinol

See all Ubiquinol clinical trials

US Patents for Ubiquinol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ubiquinol See Plans and Pricing Methods of expressing products in mammalian cells INTREXON CEU, INC. (Blacksburg, VA) See Plans and Pricing
Ubiquinol See Plans and Pricing Pre-spray emulsions and powders containing non-polar compounds Virun, Inc. (Pomona, CA) See Plans and Pricing
Ubiquinol See Plans and Pricing Nutrient combinations for affecting an aging process BioMarker Pharmaceuticals, Inc. (San Jose, CA) See Plans and Pricing
Ubiquinol See Plans and Pricing Nutritional supplement compositions containing C60-fullerene-phytonutrient-triglyceride complexes for sub-cellular phytonutrient delivery NextGen Research (Greenville, SC) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ubiquinol

Drugname Country Document Number Estimated Expiration Related US Patent
Ubiquinol World Intellectual Property Organization (WIPO) WO2012027533 2030-08-25 See Plans and Pricing
Ubiquinol Argentina AR089859 2032-02-01 See Plans and Pricing
Ubiquinol Australia AU2013215296 2032-02-01 See Plans and Pricing
Ubiquinol Brazil BR112014018957 2032-02-01 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Merck
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.